News

Medlab Asia & Asia Health 2024 event was held in Bangkok, Thailand from 10th to 12th July. At this event, Autobio held the inaugural Asia Pacific VIP Partner Meeting, which brought together regional partners to exchange market insights, discuss industry developments, and explore future collaboration opportunities.

Mr Fu Guangyu, Executive Vice President of Autobio, delivered a speech on behalf of the company. Mr Fu also highlighted Autobio's strong commitment to international business development and its dedication to expanding overseas markets, with the ultimate goal of making a positive contribution to human health. He highlighted the significance of the Asia-Pacific region in the company's global market strategy, where the population is rapidly expanding and the economy is growing at a fast pace, making it an ideal location for the thriving future of the IVD industry. Currently, there are over 1,000 units of immunological series installed in the Asia-Pacific region, with 30% of these being large and super-large instruments, and nearly 500 units of microbiological series installed, including several sets of microbiological total solutions. At Autobio, we adhere to the principle of mutual benefit and a win-win situation. We are committed to working hand in hand with our partners to continuously launch better products and services, help our partners in different regions to solve market problems, and jointly create a better future.

During the conference, partners from India, Thailand, Uzbekistan and other countries shared their marketing experience and provided practical guidance for other regions. The conference builds an open and communicative platform for partners to freely share experiences, collide ideas and explore the future development of the industry together.

In 2024 Asia Medical Laboratory Exhibition, Autobio showed up at the exhibition with fully automated microbial mass spectrometry detection system, microbial culture monitor BC60 and other products and series solutions, among which, the fully automated biochemical and immunological pipeline Autolas B-1 series was the first time to be exhibited in South Asia. The wide range of products and multi-disciplinary solutions attracted many attendees to stop by and visit the exhibition, and they gained an in-depth understanding of the latest technological achievements of Autobio through interactions and exchanges with the international business team.

The fully-automated biochemistry and immunity assembly line Autolas B-1 series can provide more than 150 magnetic particle chemiluminescence test items and 125 biochemistry test items, with a complete menu of items, which can satisfy the diversified clinical testing and intelligent needs of large and medium-sized medical laboratories. In addition, in order to meet the needs of overseas customers for laboratory intelligence, Autobio has independently developed a variety of intelligent software systems, which can achieve intelligent review of results, TAT monitoring, At the conference, partners from India, Thailand, Uzbekistan and other countries shared their marketing experience and provided practical guidance for other regions. The conference provides an open and communicative platform for partners to freely share experiences, exchange ideas and explore future industry developments together.

At the 2024 Asia Medical Laboratory Exhibition, Autobio showcased its comprehensive range of products and solutions, including the fully automated microbial mass spectrometry detection system, microbial culture monitor BC60, and the groundbreaking Autolas B-1 series, which represents the company's first foray into biochemical and immunological pipeline automation in South Asia. The extensive range of products and multi-disciplinary solutions attracted a considerable number of attendees, who took the opportunity to gain an in-depth understanding of Autobio's latest technological achievements through interactions and exchanges with our international business team.

The fully-automated biochemistry and immunity assembly line, Autolas B-1 series, is capable of providing over 150 magnetic particle chemiluminescence tests and 125 biochemistry tests, offering a comprehensive range of options to meet the diverse clinical testing and intelligent needs of large and medium-sized medical laboratories. Furthermore, to meet the demands of international clients for enhanced laboratory efficiency, Autobio has developed a range of intelligent software solutions. These include capabilities for intelligent result review, TAT monitoring, critical value alerts, automated quality control, remote service, and more.critical value warning, automatic quality control, remote service and other functions.

Medlab Asia & Asia Health, a significant event in the medical laboratory sector within the Asian region, attracted over 350 exhibitors and nearly 10,000 professionals from more than 60 countries and regions. The exhibition serves as a platform for showcasing the latest laboratory equipment and technology, while also facilitating comprehensive and professional communication, collaboration, and innovation within the medical laboratory sector.